biotech
biotech Articles
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
MyoKardia shares made an incredible gain on Monday after the company announced positive results from its late-stage pivotal clinical trial of mavacamten.
Published:
Cellect Biotechnology shares nearly doubled to start the week after the company announced progress with its bone marrow transplantation process.
Published:
These are five of the best stocks in a sector that has been humming along in what has been a turbulent year. They are all included on the Goldman Sachs Conviction List too.
Published:
Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment.
Published:
Regeneron Pharmaceuticals reported its first-quarter financial results before the markets opened on Tuesday. While the earnings were important, and fairly positive, more investors seemed interested...
Published:
Portola Pharmaceuticals shares more than doubled on Tuesday after the company announced that it would be acquired by Alexion Pharmaceuticals.
Published:
Applied DNA Sciences shares shot up on Monday after the company announced an update to its COVID-19 vaccine program.
Published:
When a raging bull market dies and turns into a bear market with a deep recession in less than 45 days, things are not normal. The same is true when the stock market recovers about two-thirds of its...
Published:
iBio has provided an update on its COVID-19 vaccine manufacturing capacity and said that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals.
Published:
As there is currently no FDA-approved treatment for Alzheimer’s agitation, any progress here could be lucrative. Axsome Therapeutics has announced a big step forward in its midstage Alzheimer’s...
Published:
Aytu BioScience shares made an incredible gain to start the week following the firm’s announcement in regards to a coronavirus treatment.
Published:
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies is a proverbial one-trick pony, and they all are potential takeover...
Published:
Mesoblast shares more than doubled on Friday after the company provided an update on its COVID-19 treatment. Should it be taken with a grain of salt?
Published: